MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games

ELAN Trial

Search medical newsFind research, conditions and clinical updates
  • Home
  • ELAN Trial
Impact of Prior Reperfusion Strategies on Early versus Late Direct Oral Anticoagulation in Ischemic Stroke: Insights from the ELAN Trial Subanalysis
Posted inClinical Updates Neurology news Specialties

Impact of Prior Reperfusion Strategies on Early versus Late Direct Oral Anticoagulation in Ischemic Stroke: Insights from the ELAN Trial Subanalysis

Posted by By MedXY 08/17/2025
A subanalysis of the ELAN trial shows that prior reperfusion therapy does not alter the safety or efficacy outcomes of early versus late initiation of direct oral anticoagulants in ischemic stroke patients with atrial fibrillation.
Read More

Take a game break

Explore a few games from MedXY.

Explore all games
  • Beyond Abstinence: Multidisciplinary Approaches Enhance Long-Term Outcomes After Liver Transplantation for Alcohol-Associated Liver Disease
  • Assessing Accuracy and Utility of Melanoma Risk Prediction Models in an Australian Cohort
  • A Minimum Standard Set for Reporting Lymphatic Surgery Outcomes: What the Society of Lymphatic Surgery Consensus Means for Practice
  • Putting People First in ICU Care: ESICM’s 2026 Consensus on Human-Centred Partnership
  • Force Multiplication in Body Contouring: Enhancing Access and Conversion through Advanced Practice Provider Clinics
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk case report chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation machine learning MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top